Boehringer Ingelheim

GLP-1 medications are a significant medical advance, but they can be very expensive without insurance. The cash price can vary widely depending on the specific medication, dosage, and the pharmacy you use, but it's generally in the range of $900 to $1,800+ per month. Here's a breakdown of common GLP-1 medications and their estimated monthly costs without insurance: Semaglutide Ozempic (injectable): Used for type 2 diabetes, often prescribed off-label for weight loss. Estimated Monthly Cost Without Insurance: Roughly $900 - $1,300. Wegovy (injectable): Specifically approved for chronic weight management. Estimated Monthly Cost Without Insurance: Roughly $1,300 - $1,600. Rybelsus (oral): Used for type 2 diabetes. Estimated Monthly Cost Without Insurance: Roughly $900 - $1,300. Tirzepatide Mounjaro (injectable): Used for type 2 diabetes, also known for significant weight loss. Estimated Monthly Cost Without Insurance: Roughly $1,000 - $1,400. Zepbound (injectable): Specifically approved for chronic weight management. Estimated Monthly Cost Without Insurance: Roughly $1,100 - $1,500. Liraglutide Victoza (injectable): Used for type 2 diabetes. Estimated Monthly Cost Without Insurance: Roughly $1,300 - $1,700. (Note: This is a daily injection, which contributes to the higher cost per month due to the volume of medication needed). Saxenda (injectable): Specifically approved for chronic weight management. Estimated Monthly Cost Without Insurance: Roughly $1,300 - $1,700. Dulaglutide Trulicity (injectable): Used for type 2 diabetes. Estimated Monthly Cost Without Insurance: Roughly $900 - $1,400. Why the High Cost? These medications are proprietary, relatively new, and have proven highly effective for their approved uses. The manufacturers (Eli Lilly for Mounjaro/Zepbound, Novo Nordisk for Ozempic/Wegovy/Rybelsus/Saxenda/Victoza, and Boehringer Ingelheim/Eli Lilly for Trulicity) set the cash prices, and they are typically very high to recoup research and development costs. Strategies to Potentially Reduce Costs (Even Without Insurance): Manufacturer Savings Programs: Eli Lilly (Mounjaro/Zepbound): Visit the Mounjaro Savings Card or Zepbound Savings Card websites. While many programs are designed for commercially insured patients, sometimes there are options or specific coupons for those without insurance or who meet certain income criteria. Novo Nordisk (Ozempic/Wegovy/Saxenda/Rybelsus): Check the NovoCare® program on their websites. They may have patient assistance programs for eligible low-income, uninsured individuals. Discount Cards/Coupons: GoodRx: Can often provide significant discounts on prescription medications. Enter the drug name and your zip code to compare prices at local pharmacies. SingleCare: Another excellent option for prescription discounts. Optum Perks, RxSaver, etc.: Many other similar services exist. Talk to Your Doctor: Your doctor may have samples available or be aware of other local programs or less expensive alternatives. They can also help you understand if these medications are medically necessary for you. Compounding Pharmacies (Use with Caution): Some compounding pharmacies offer GLP-1s at a lower cost. However, it's crucial to understand: These are not* the FDA-approved brand-name drugs. They are chemically similar compounds (e.g., semaglutide sodium or semaglutide acetate instead of semaglutide base). The FDA has expressed concerns about the safety and efficacy of compounded versions, as they are not subject to the same rigorous testing and quality control. Always ensure the compounding pharmacy is reputable and licensed, and discuss this option thoroughly with your doctor. International Pharmacies (Use with Extreme Caution): Some people look to import medications from other countries where prices may be lower. This can be risky due to questions of quality, safety, legality, and potential scams. The FDA generally advises against importing drugs. Given the high cost, it's highly recommended to explore all available savings options and discuss them thoroughly with your healthcare provider.

Mentioned in position 3 of 10